Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?

Published:2020-12 Issue:12 Volume:40 Page:6769-6780
ISSN:0250-7005
Container-title:Anticancer Research
language:en
Short-container-title:Anticancer Res

Author:

DE BREE EELCO,KATSOUGKRI DESPOINA,POLIOUDAKI HARA,TSANGARIDOU ELENA,MICHELAKIS DIMOSTHENIS,ZORAS ODYSSEAS,THEODOROPOULOS PANAYIOTIS

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Oncology,General Medicine

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional targeting of docetaxel plus bakuchiol micelles in the treatment of invasion and metastasis of ovarian cancer;Biomedical Materials;2024-09-05

2. Clinical significance of peritoneal cancers;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

3. The 2022 PSOGI International Consensus on HIPEC Regimens for Peritoneal Malignancies: Epithelial Ovarian Cancer;Annals of Surgical Oncology;2023-08-10

4. Ten-year treatment outcomes of consolidation hyperthermic intraperitoneal chemotherapy for ovarian cancer (HIPEC-KOV-03R);Journal of Gynecologic Oncology;2023

5. Clinical efficacy of hyperthermic intraperitoneal chemotherapy on the malignant ascites in gastric cancer patients following the preoperative radiotherapy;INT J RADIAT RES;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP